Roger Chen

Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α

Laura G. Corral, Patrick Haslett, George W. Muller et al. · The Journal of Immunology · 1999 · 652 citations · Full text

Immunology, Immune Regulation, Immunologic Mechanism +18

Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells

Lei Wu, Mary Adams, Troy Carter et al. · Clinical Cancer Research · 2008 · 431 citations · Full text

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

Christine Galustian, B Meyer, Marie‐Christine Labarthe et al. · Cancer Immunology Immunotherapy · 2008 · 384 citations · Full text

Anti-cancer Agents, Cancer Immunosurveillance, Medicine +10

Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production

George W. Muller, Roger Chen, Shaei‐Yun Huang et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 337 citations

Molecular Pharmacology, Medicinal Chemistry, Medicine +7

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9